The DOI matches its Crossref record; 176 of the 176 references it cites were found in a registry or an index.
Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease
Open accessAbstract
OBJECTIVEdData on cardiac function in patients with nonalcoholic fatty liver disease (NAFLD) are limited and conflicting.We assessed whether NAFLD is associated with abnormalities in cardiac function in patients with type 2 diabetes.RESEARCH DESIGN AND METHODSdWe studied 50 consecutive type 2 diabetic individuals without a history of ischemic heart disease, hepatic diseases, or excessive alcohol consumption, in whom NAFLD was diagnosed by ultrasonography.A tissue Doppler echocardiography with myocardial strain measurement was performed in all patients.RESULTSdThirty-two patients (64%) had NAFLD, and when compared with the other 18 patients, age, sex, BMI, waist circumference, hypertension, smoking, diabetes duration, microvascular complication status, and medication use were not significantly different.In addition, the left ventricular (LV) mass and volumes, ejection fraction, systemic vascular resistance, arterial elasticity, and compliance were also not different.NAFLD patients had lower e9 (8.2 6 1.5 vs. 9.9 6 1.9 cm/s, P , 0.005) tissue velocity, higher E-to-e9 ratio (7.90 6 1.3 vs. 5.59 6 1.1, P , 0.0001), a higher time constant of isovolumic relaxation (43.1 6 10.1 vs. 33.26 12.9 ms, P , 0.01), higher LV-end diastolic pressure (EDP) (16.5 6 1.1 vs. 15.1 6 1.0 mmHg, P , 0.0001), and higher LV EDP/end diastolic volume (0.20 6 0.03 vs. 0.18 6 0.02 mmHg, P , 0.05) than those without steatosis.Among the measurements of LV global longitudinal strain and strain rate, those with NAFLD also had higher E/global longitudinal diastolic strain rate during the early phase of diastole (E/SR E ).All of these differences remained significant after adjustment for hypertension and other cardiometabolic risk factors.CONCLUSIONSdOur data show that in patients with type 2 diabetes and NAFLD, even if the LV morphology and systolic function are preserved, early features of LV diastolic dysfunction may be detected.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Zhou, Y. J., Li, Y. Y., Nie, Y. Q., Huang, C., & Cao, C. Y. (2011) · Journal of Digestive Diseases · doi:10.1111/j.1751-2980.2011.00571.x · Cited by 93
Retracted(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,803
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
Bedogni, G., Bellentani, S., Miglioli, L., Masutti, F., Passalacqua, M., Castiglione, A., & Tiribelli, C. (2006) · BMC Gastroenterology · doi:10.1186/1471-230x-6-33 · Cited by 3,042
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Ekstedt, M., Franzén, L. E., Mathiesen, U. L., Thorelius, L., Holmqvist, M., Bodemar, G., & Kechagias, S. (2006) · Hepatology · doi:10.1002/hep.21327 · Cited by 2,302
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
Targher, G., Day, C. P., & Bonora, E. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0912063 · Cited by 1,907
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
Anstee, Q. M., Targher, G., & Day, C. P. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.41 · Cited by 1,747
Otto, C. M., Kuusisto, J., Reichenbach, D. D., Gown, A. M., & O'Brien, K. D. (1994) · Circulation · doi:10.1161/01.cir.90.2.844 · Cited by 1,315
Musso, G., Gambino, R., Cassader, M., & Pagano, G. (2011) · Annals of Medicine · doi:10.3109/07853890.2010.518623 · Cited by 1,293
Heart rate variability: measurement and clinical utility.
Kleiger, R. E., Stein, P. K., & Bigger, J. T. (2005) · Annals of Noninvasive Electrocardiology · doi:10.1111/j.1542-474x.2005.10101.x · Cited by 1,290
Association of Aortic-Valve Sclerosis with Cardiovascular Mortality and Morbidity in the Elderly
Otto, C. M., Lind, B. K., Kitzman, D. W., Gersh, B. J., & Siscovick, D. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907153410302 · Cited by 1,283
Vitamin D Receptor As an Intestinal Bile Acid Sensor
Makishima, M., Lu, T. T., Xie, W., Whitfield, G. K., Domoto, H., Evans, R. M., Haussler, M. R., & Mangelsdorf, D. J. (2002) · Science · doi:10.1126/science.1070477 · Cited by 1,176
A position statement on NAFLD/NASH based on the EASL 2009 special conference
Ratziu, V., Bellentani, S., Cortez-Pinto, H., Day, C., & Marchesini, G. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.04.008 · Cited by 1,058
Targher, G., Bertolini, L., Padovani, R., Rodella, S., Tessari, R., Zenari, L., Day, C., & Arcaro, G. (2007) · Diabetes Care · doi:10.2337/dc06-2247 · Cited by 992
Prolonged QTc Interval and Risk of Sudden Cardiac Death in a Population of Older Adults
Straus, S. M. J. M., Kors, J. A., De Bruin, M. L., van der Hooft, C. S., Hofman, A., Heeringa, J., Deckers, J. W., Kingma, J. H., Sturkenboom, M. C. J. M., Stricker, B. H. C., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.067 · Cited by 833
Kim, D., Kim, R. W., Kim, H. J., & Therneau, T. M. (2013) · Hepatology · doi:10.1002/hep.26156 · Cited by 772
Decreased Survival of Subjects With Elevated Liver Function Tests During A 28-Year Follow-Up
Söderberg, C., Stål, P., Askling, J., Glaumann, H., Lindberg, G., Marmur, J., & Hultcrantz, R. (2010) · Hepatology · doi:10.1002/hep.23314 · Cited by 754
High-Density Lipoprotein Subfractions - What the Clinicians Need to Know
Pirillo, A., Norata, G. D., & Catapano, A. L. (2013) · Cardiology · doi:10.1159/000346463 · Cited by 748
Long-Term Follow-Up of Patients With Nonalcoholic Fatty Liver
Rafiq, N., Bai, C., Fang, Y., Srishord, M., McCullough, A., Gramlich, T., & Younossi, Z. M. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.11.005 · Cited by 729
Lee, J. H., O'Keefe, J. H., Bell, D., Hensrud, D. D., & Holick, M. F. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.050 · Cited by 724
Klonoff, D. C., Buse, J. B., Nielsen, L. L., Guan, X., Bowlus, C. L., Holcombe, J. H., Wintle, M. E., & Maggs, D. G. (2008) · Current Medical Research and Opinion · doi:10.1185/030079908x253870 · Cited by 699
Athyros, V. G., Tziomalos, K., Gossios, T. D., Griva, T., Anagnostis, P., Kargiotis, K., Pagourelias, E. D., Theocharidou, E., Karagiannis, A., & Mikhailidis, D. P. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61272-x · Cited by 685
Musso, G., Cassader, M., Rosina, F., & Gambino, R. (2012) · Diabetologia · doi:10.1007/s00125-011-2446-4 · Cited by 661
Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease
Ong, J. P., Pitts, A., & Younossi, Z. M. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.06.018 · Cited by 638
Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease†
Villanova, N., Moscatiello, S., Ramilli, S., Bugianesi, E., Magalotti, D., Vanni, E., Zoli, M., & Marchesini, G. (2005) · Hepatology · doi:10.1002/hep.20781 · Cited by 629
Algra, A., Tijssen, J. G., Roelandt, J. R., Pool, J., & Lubsen, J. (1991) · Circulation · doi:10.1161/01.cir.83.6.1888 · Cited by 592
Targher, G., Bertolini, L., Rodella, S., Tessari, R., Zenari, L., Lippi, G., & Arcaro, G. (2007) · Diabetes Care · doi:10.2337/dc07-0349 · Cited by 579
Omega-3 supplementation and non-alcoholic fatty liver disease: A systematic review and meta-analysis
Parker, H. M., Johnson, N. A., Burdon, C. A., Cohn, J. S., O’Connor, H. T., & George, J. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.08.018 · Cited by 569
Rijzewijk, L. J., van der Meer, R. W., Smit, J. W. A., Diamant, M., Bax, J. J., Hammer, S., Romijn, J. A., de Roos, A., & Lamb, H. J. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.07.062 · Cited by 559
Exercise and non-alcoholic fatty liver disease: A systematic review and meta-analysis
Keating, S. E., Hackett, D. A., George, J., & Johnson, N. A. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.023 · Cited by 537
Hallsworth, K., Fattakhova, G., Hollingsworth, K. G., Thoma, C., Moore, S., Taylor, R., Day, C. P., & Trenell, M. I. (2011) · Gut · doi:10.1136/gut.2011.242073 · Cited by 529
Thoma, C., Day, C. P., & Trenell, M. I. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.06.010 · Cited by 523
Exercise as a Mean to Control Low‐Grade Systemic Inflammation
Mathur, N., & Pedersen, B. K. (2008) · Mediators of Inflammation · doi:10.1155/2008/109502 · Cited by 514
Mechanisms of vascular damage in obstructive sleep apnea
Kohler, M., & Stradling, J. R. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.145 · Cited by 513
n–3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors
The Risk and Prevention Study Collaborative Group (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205409 · Cited by 510
Long term prognosis of fatty liver: risk of chronic liver disease and death
Dam-Larsen, S., Franzmann, M., Andersen, I. B., Christoffersen, P., Jensen, L. B., Sørensen, T. I. A., Becker, U., & Bendtsen, F. (2004) · Gut · doi:10.1136/gut.2003.019984 · Cited by 508
Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?
Bhatia, L. S., Curzen, N. P., Calder, P. C., & Byrne, C. D. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr453 · Cited by 496
Yokohama, S., Yoneda, M., Haneda, M., Okamoto, S., Okada, M., Aso, K., Hasegawa, T., Tokusashi, Y., Miyokawa, N., & Nakamura, K. (2004) · Hepatology · doi:10.1002/hep.20420 · Cited by 458
Targher, G., Bertolini, L., Scala, L., Cigolini, M., Zenari, L., Falezza, G., & Arcaro, G. (2007) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2006.04.002 · Cited by 440
Schindhelm, R. K., Dekker, J. M., Nijpels, G., Bouter, L. M., Stehouwer, C. D. A., Heine, R. J., & Diamant, M. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.04.006 · Cited by 420
Sookoian, S., & Pirola, C. J. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.06.012 · Cited by 406
Targher, G., Bertolini, L., Padovani, R., Rodella, S., Zoppini, G., Zenari, L., Cigolini, M., Falezza, G., & Arcaro, G. (2006) · Diabetes Care · doi:10.2337/dc06-0135 · Cited by 401
Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study
Lazo, M., Hernaez, R., Bonekamp, S., Kamel, I. R., Brancati, F. L., Guallar, E., & Clark, J. M. (2011) · BMJ · doi:10.1136/bmj.d6891 · Cited by 395
Chen, H.-P., Shieh, J.-J., Chang, C.-C., Chen, T.-T., Lin, J.-T., Wu, M.-S., Lin, J.-H., & Wu, C.-Y. (2013) · Gut · doi:10.1136/gutjnl-2011-301708 · Cited by 392
Ruhl, C. E., & Everhart, J. E. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.052 · Cited by 352
Stepanova, M., & Younossi, Z. M. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.12.039 · Cited by 352
Bacchi, E., Negri, C., Targher, G., Faccioli, N., Lanza, M., Zoppini, G., Zanolin, E., Schena, F., Bonora, E., & Moghetti, P. (2013) · Hepatology · doi:10.1002/hep.26393 · Cited by 350
Lip, G. Y., Tse, H. F., & Lane, D. A. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61514-6 · Cited by 338
From NAFLD in clinical practice to answers from guidelines
Nascimbeni, F., Pais, R., Bellentani, S., Day, C. P., Ratziu, V., Loria, P., & Lonardo, A. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.05.044 · Cited by 337
Aminotransferase Levels and 20-Year Risk of Metabolic Syndrome, Diabetes, and Cardiovascular Disease
Goessling, W., Massaro, J. M., Vasan, R. S., D'Agostino, R. B., Ellison, R. C., & Fox, C. S. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.09.018 · Cited by 330
Omega‐3 Dietary Supplements and the Risk of Cardiovascular Events: A Systematic Review
Marik, P. E., & Varon, J. (2009) · Clinical Cardiology · doi:10.1002/clc.20604 · Cited by 328
Suspected Nonalcoholic Fatty Liver Disease and Mortality Risk in a Population-Based Cohort Study
Dunn, W., Xu, R., Wingard, D. L., Rogers, C., Angulo, P., Younossi, Z. M., & Schwimmer, J. B. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.02034.x · Cited by 325
Singh, S., Singh, P. P., Singh, A. G., Murad, M. H., & Sanchez, W. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.5 · Cited by 320
Nonalcoholic fatty liver disease is associated with coronary artery calcification
Kim, D., Choi, S.-Y., Park, E. H., Lee, W., Kang, J. H., Kim, W., Kim, Y. J., Yoon, J.-H., Jeong, S. H., Lee, D. H., et al. (2012) · Hepatology · doi:10.1002/hep.25593 · Cited by 310
Targher, G., & Byrne, C. D. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3093 · Cited by 297
Wong, V. W.-S., Wong, G. L.-H., Yip, G. W.-K., Lo, A. O.-S., Limquiaco, J., Chu, W. C.-W., Chim, A. M.-L., Yu, C.-M., Yu, J., Chan, F. K.-L., et al. (2011) · Gut · doi:10.1136/gut.2011.242016 · Cited by 296
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease
Loria, P., Adinolfi, L. E., Bellentani, S., Bugianesi, E., Grieco, A., Fargion, S., Gasbarrini, A., Loguercio, C., Lonardo, A., Marchesini, G., et al. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.01.021 · Cited by 294
Prevention of Type 2 Diabetes Mellitus Through Inhibition of the Renin-Angiotensin System
Scheen, A. J. (2004) · Drugs · doi:10.2165/00003495-200464220-00004 · Cited by 293
Ezetimibe therapy: mechanism of action and clinical update
Toth, P., Phan, & Dayspring, T. (2012) · Vascular Health and Risk Management · doi:10.2147/vhrm.s33664 · Cited by 288
Neumann, A., Weill, A., Ricordeau, P., Fagot, J. P., Alla, F., & Allemand, H. (2012) · Diabetologia · doi:10.1007/s00125-012-2538-9 · Cited by 284
Trevaskis, J. L., Griffin, P. S., Wittmer, C., Neuschwander-Tetri, B. A., Brunt, E. M., Dolman, C. S., Erickson, M. R., Napora, J., Parkes, D. G., & Roth, J. D. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00476.2011 · Cited by 277
Fraser, A., Harris, R., Sattar, N., Ebrahim, S., Smith, G. D., & Lawlor, D. A. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.152298 · Cited by 277
Meta-analysis: vitamin D and non-alcoholic fatty liver disease
Eliades, M., Spyrou, E., Agrawal, N., Lazo, M., Brancati, F. L., Potter, J. J., Koteish, A. A., Clark, J. M., Guallar, E., & Hernaez, R. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12377 · Cited by 273
Liu, T., Li, G., Li, L., & Korantzopoulos, P. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.12.042 · Cited by 268
Musso, G., Cassader, M., Olivetti, C., Rosina, F., Carbone, G., & Gambino, R. (2013) · Obesity Reviews · doi:10.1111/obr.12020 · Cited by 254
Fatty liver index and mortality: The cremona study in the 15th year of follow-up
Calori, G., Lattuada, G., Ragogna, F., Garancini, M. P., Crosignani, P., Villa, M., Bosi, E., Ruotolo, G., Piemonti, L., & Perseghin, G. (2011) · Hepatology · doi:10.1002/hep.24356 · Cited by 253
Haring, R., Wallaschofski, H., Nauck, M., Dörr, M., Baumeister, S. E., & Völzke, H. (2009) · Hepatology · doi:10.1002/hep.23135 · Cited by 245
The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis†
Lutchman, G., Modi, A., Kleiner, D. E., Promrat, K., Heller, T., Ghany, M., Borg, B., Loomba, R., Liang, T. J., Premkumar, A., et al. (2007) · Hepatology · doi:10.1002/hep.21661 · Cited by 244
Targher, G., Bertolini, L., Padovani, R., Rodella, S., Zoppini, G., Pichiri, I., Sorgato, C., Zenari, L., & Bonora, E. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.04.030 · Cited by 235
Cuthbertson, D. J., Irwin, A., Gardner, C. J., Daousi, C., Purewal, T., Furlong, N., Goenka, N., Thomas, E. L., Adams, V. L., Pushpakom, S. P., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050117 · Cited by 226
Coronary heart disease prevention: Nutrients, foods, and dietary patterns
Bhupathiraju, S. N., & Tucker, K. L. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.04.038 · Cited by 225
Triglycerides and Heart Disease: Still a Hypothesis?
Goldberg, I. J., Eckel, R. H., & McPherson, R. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.226100 · Cited by 219
Nonalcoholic fatty liver disease and serum lipoproteins: The Multi-Ethnic Study of Atherosclerosis
DeFilippis, A. P., Blaha, M. J., Martin, S. S., Reed, R. M., Jones, S. R., Nasir, K., Blumenthal, R. S., & Budoff, M. J. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.01.022 · Cited by 217
NASH Predicts Plasma Inflammatory Biomarkers Independently of Visceral Fat in Men
Targher, G., Bertolini, L., Rodella, S., Lippi, G., Franchini, M., Zoppini, G., Muggeo, M., & Day, C. P. (2008) · Obesity · doi:10.1038/oby.2008.64 · Cited by 214
Perseghin, G., Lattuada, G., De Cobelli, F., Esposito, A., Belloni, E., Ntali, G., Ragogna, F., Canu, T., Scifo, P., Del Maschio, A., et al. (2008) · Hepatology · doi:10.1002/hep.21983 · Cited by 210
The cardiovascular safety of diabetes drugs–insights from the rosiglitazone experience
Hiatt, W. R., Kaul, S., & Smith, R. J. (2013) · New England Journal of Medicine · doi:10.1056/nejmp1309610 · Cited by 204
Newton, J. L., Jones, D. E. J., Henderson, E., Kane, L., Wilton, K., Burt, A. D., & Day, C. P. (2008) · Gut · doi:10.1136/gut.2007.139303 · Cited by 201
Insulin Resistance and Atherosclerosis
Razani, B., Chakravarthy, M. V., & Semenkovich, C. F. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.05.001 · Cited by 199
Targher, G., Valbusa, F., Bonapace, S., Bertolini, L., Zenari, L., Rodella, S., Zoppini, G., Mantovani, W., Barbieri, E., & Byrne, C. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057183 · Cited by 197
Relation of Nonalcoholic Hepatic Steatosis to Early Carotid Atherosclerosis in Healthy Men
Targher, G., Bertolini, L., Padovani, R., Zenari, L., Zoppini, G., & Falezza, G. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2498 · Cited by 197
Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease
Park, H., Shima, T., Yamaguchi, K., Mitsuyoshi, H., Minami, M., Yasui, K., Itoh, Y., Yoshikawa, T., Fukui, M., Hasegawa, G., et al. (2011) · Journal of Gastroenterology · doi:10.1007/s00535-010-0291-8 · Cited by 195
Positive feedback sharpens the anaphase switch
Holt, L. J., Krutchinsky, A. N., & Morgan, D. O. (2008) · Nature · doi:10.1038/nature07050 · Cited by 193
Presence of Coronary Plaques in Patients with Nonalcoholic Fatty Liver Disease
Assy, N., Djibre, A., Farah, R., Grosovski, M., & Marmor, A. (2010) · Radiology · doi:10.1148/radiol.09090769 · Cited by 192
Bonapace, S., Perseghin, G., Molon, G., Canali, G., Bertolini, L., Zoppini, G., Barbieri, E., & Targher, G. (2012) · Diabetes Care · doi:10.2337/dc11-1820 · Cited by 183
Verrijken, A., Francque, S., Mertens, I., Prawitt, J., Caron, S., Hubens, G., Van Marck, E., Staels, B., Michielsen, P., & Van Gaal, L. (2014) · Hepatology · doi:10.1002/hep.26510 · Cited by 181
Ndumele, C. E., Nasir, K., Conceiçao, R. D., Carvalho, J. A. M., Blumenthal, R. S., & Santos, R. D. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.228262 · Cited by 179
The F ramingham risk score and heart disease in nonalcoholic fatty liver disease
Treeprasertsuk, S., Leverage, S., Adams, L. A., Lindor, K. D., Sauver, J. L. S., & Angulo, P. (2012) · Liver International · doi:10.1111/j.1478-3231.2011.02753.x · Cited by 171
Fatty Liver, Insulin Resistance, and Features of Metabolic Syndrome
Sung, K., Wild, S. H., Kwag, H. J., & Byrne, C. D. (2012) · Diabetes Care · doi:10.2337/dc12-0515 · Cited by 170
Lautamäki, R., Borra, R., Iozzo, P., Komu, M., Lehtimäki, T., Salmi, M., Jalkanen, S., Airaksinen, K. E. J., Knuuti, J., Parkkola, R., et al. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00604.2005 · Cited by 170
Younossi, Z. M., Otgonsuren, M., Venkatesan, C., & Mishra, A. (2013) · Metabolism · doi:10.1016/j.metabol.2012.08.005 · Cited by 169
Bae, J. C., Suh, S., Park, S. E., Rhee, E. J., Park, C. Y., Oh, K. W., Park, S. W., Kim, S. W., Hur, K. Y., Kim, J. H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046819 · Cited by 166
Tikkanen, M. J., Fayyad, R. S., Færgeman, O., OLSSON, A. G., Wun, C., Laskey, R. E., Kastelein, J. J. P., Holme, I., & Pedersen, T. R. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.06.024 · Cited by 164
Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease
Hallsworth, K., Hollingsworth, K. G., Thoma, C., Jakovljević, D. G., MacGowan, G. A., Anstee, Q. M., Taylor, R., Day, C. P., & Trenell, M. I. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.11.015 · Cited by 162
Goland, S., Shimoni, S., Zornitzki, T., Knobler, H., Azoulai, O., Lutaty, G., Melzer, E., Orr, A., Caspi, A., & Malnick, S. (2006) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000225668.53673.e6 · Cited by 162
Fitness Versus Fatness: Moving Beyond Weight Loss in Nonalcoholic Fatty Liver Disease
Johnson, N. A., & George, J. (2010) · Hepatology · doi:10.1002/hep.23711 · Cited by 161
Renin‐Angiotensin‐Aldosterone System in Diabetes and Hypertension
Hsueh, W. A., & Wyne, K. (2011) · The Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2011.00449.x · Cited by 160
Meta‐analysis: insulin sensitizers for the treatment of non‐alcoholic steatohepatitis
Rakoski, M. O., Singal, A. G., Rogers, M. A. M., & Conjeevaram, H. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04467.x · Cited by 158
Prognosis of patients with a diagnosis of fatty liver--a registry-based cohort study.
Jepsen, P., Vilstrup, H., Mellemkjær, L., Thulstrup, A. M., Olsen, J. H., Baron, J. A., & Sørensen, H. T. (2003) · PubMed · Cited by 152
Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis
Zhang, H., Gao, C., Fang, L., Zhao, H.-C., & Yao, S. (2012) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2012.719926 · Cited by 148
Sonographic fatty liver, overweight and ischemic heart disease
Lin, Y., Lo, H.-M., & Chen, J.-D. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i31.4838 · Cited by 142
Yun, K. E., Shin, C. Y., Yoon, Y. S., & Park, H. S. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.12.012 · Cited by 134
Rooyen, D. M. V., Gan, L. T., Yeh, M. M., Haigh, W. G., Larter, C. Z., Ioannou, G. N., Teoh, N., & Farrell, G. C. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.02.024 · Cited by 132
Targher, G., Mantovani, A., Pichiri, I., Rigolon, R., Dauriz, M., Zoppini, G., Morani, G., Vassanelli, C., & Bonora, E. (2013) · Clinical Science · doi:10.1042/cs20130036 · Cited by 129
Fatty Liver, Abdominal Visceral Fat, and Cardiometabolic Risk Factors: The Jackson Heart Study
Liu, J., Fox, C. S., Hickson, D. A., Bidulescu, A., Carr, J. J., & Taylor, H. A. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.234062 · Cited by 129
Effects of Hepatic Triglyceride Content on Myocardial Metabolism in Type 2 Diabetes
Rijzewijk, L. J., Jonker, J. T., van der Meer, R. W., Lubberink, M., de Jong, H. W. A. M., Romijn, J. A., Bax, J. J., Roos, A., Heine, R. J., Twisk, J. W. R., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.02.049 · Cited by 127
Musso, G., Cassader, M., De Michieli, F., Rosina, F., Orlandi, F., & Gambino, R. (2012) · Hepatology · doi:10.1002/hep.25739 · Cited by 126
Effects of combined exenatide and pioglitazone therapy on hepatic fat content in type 2 diabetes
Sathyanarayana, P., Jogi, M., Muthupillai, R., Krishnamurthy, R., Samson, S. L., & Bajaj, M. (2011) · Obesity · doi:10.1038/oby.2011.152 · Cited by 124
Okin, P. M., Devereux, R. B., Lee, E. T., Galloway, J. M., & Howard, B. V. (2004) · Diabetes · doi:10.2337/diabetes.53.2.434 · Cited by 124
Akabame, S., Hamaguchi, M., Tomiyasu, K.-I., Tanaka, M., Kobayashi-Takenaka, Y., Nakano, K., Oda, Y., & Yoshikawa, T. (2007) · Circulation Journal · doi:10.1253/circj.72.618 · Cited by 123
Increased arterial stiffness in nonalcoholic fatty liver disease: the Cardio-GOOSE study
Salvi, P., Ruffini, R., Agnoletti, D., Magnani, E., Pagliarani, G., Comandini, G., Praticò, A., Borghi, C., Bénétos, A., & Pazzi, P. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e32833a7de6 · Cited by 120
Fallo, F., Pozza, A. D., Sonino, N., Lupia, M., Tona, F., Federspil, G., Ermani, M., Catena, C., Soardo, G., Piazza, L. D., et al. (2009) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.12.007 · Cited by 118
Fotbolcu, H., Yakar, T., Duman, D., Karaahmet, T., Tigen, K., Çevik, C., Kurtoğlu, Ü., & Dindar, İ. (2010) · PubMed · Cited by 117
Association Between Nonalcoholic Fatty Liver Disease and Coronary Artery Calcification
Chen, C., Nien, C., Yang, C., & Yeh, Y. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0935-9 · Cited by 114
Barasch, E., Gottdiener, J. S., Larsen, E. K. M., Chaves, P. H. M., & Newman, A. B. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.11.065 · Cited by 112
Association between nonalcoholic fatty liver disease and coronary artery disease
Arslan, U., Türkoğlu, S., Balcıoğlu, S., Tavıl, Y., Karakan, T., & Çengel, A. (2007) · Coronary Artery Disease · doi:10.1097/mca.0b013e3282583c0d · Cited by 110
Functional and Morphological Vascular Changes in Pediatric Nonalcoholic Fatty Liver Disease
Pacifico, L., Anania, C., Martino, F., Cantisani, V., Pascone, R., Marcantonio, A., & Chiesa, C. (2010) · Hepatology · doi:10.1002/hep.23890 · Cited by 109
Left Ventricular Dysfunction in Obese Children and Adolescents With Nonalcoholic Fatty Liver Disease
Pacifico, L., Martino, M. D., Merulis, A. D., Bezzi, M., Osborn, J. F., Catalano, C., & Chiesa, C. (2013) · Hepatology · doi:10.1002/hep.26610 · Cited by 109
Sookoian, S. C., Gianotti, T. F., Rosselli, M. S., Burgueño, A. L., Castaño, G. O., & Pirola, C. J. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.05.014 · Cited by 105
GLP-1 receptor agonists: A clinical perspective on cardiovascular effects
Mundil, D., Cameron-Vendrig, A., & Husain, M. (2012) · Diabetes and Vascular Disease Research · doi:10.1177/1479164112441526 · Cited by 104
Serum γ-Glutamyl Transferase and Risk of Heart Failure in the Community
Dhingra, R., Gona, P. N., Wang, T. J., Fox, C. S., D’Agostino, R. B., & Vasan, R. S. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.207340 · Cited by 102
Relation of Circulating Liver Transaminase Concentrations to Risk of New-Onset Atrial Fibrillation
Sinner, M. F., Wang, N., Fox, C. S., Fontes, J. D., Rienstra, M., Magnani, J. W., Vasan, R. S., Calderwood, A. H., Pencina, M. J., SULLIVAN, L. M., et al. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.09.021 · Cited by 99
Yilmaz, Y. N., Kurt, R., Yönal, O., Polat, N., Çelikel, Ç., Gürdal, A., Oflaz, H., Ozdogan, O. C., İmeryüz, N., Kalaycı, C., et al. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.01.049 · Cited by 97
Abdulla, J., Asferg, C. L., & Kofoed, K. F. (2010) · International journal of cardiac imaging · doi:10.1007/s10554-010-9652-x · Cited by 96
Liu, J., Musani, S. K., Bidulescu, A., Carr, J. J., Wilson, J. G., Taylor, H. A., & Fox, C. S. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.07.042 · Cited by 95
Systemic Symptoms in Non-Alcoholic Fatty Liver Disease
Newton, J. L. (2010) · Digestive Diseases · doi:10.1159/000282089 · Cited by 93
Liu, Y., Hung, C., Wu, Y., Lee, Y.-C., Lin, Y., Lin, C., Lo, M., Chan, C.-C., Ma, H., Ho, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061803 · Cited by 88
Kudo, H., Yata, Y., Takahara, T., Kawai, K., Nakayama, Y., Kanayama, M., Oya, T., Morita, S., Sasahara, M., Mann, D. A., et al. (2009) · Liver International · doi:10.1111/j.1478-3231.2009.02006.x · Cited by 88
Assessment of endothelial function in patients with nonalcoholic fatty liver disease
Çolak, Y., Şenateş, E., Yeşıl, A., Yilmaz, Y. N., Öztürk, O., Doğanay, H. L., Coşkunpınar, E. M., Kahraman, Ö. T., Mesçi, B., Ulaşoğlu, C., et al. (2012) · Endocrine · doi:10.1007/s12020-012-9712-1 · Cited by 86
Vitamin D, Thrombosis, and Hemostasis: More than Skin Deep
Targher, G., Pichiri, I., & Lippi, G. (2012) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0031-1300957 · Cited by 81
Fatigue and autonomic dysfunction in non-alcoholic fatty liver disease
Newton, J. L., Pairman, J., Wilton, K., Jones, D. E. J., & Day, C. P. (2009) · Clinical Autonomic Research · doi:10.1007/s10286-009-0031-4 · Cited by 80
Ratziu, V., Caldwell, S. H., & Neuschwander‐Tetri, B. A. (2010) · Hepatology · doi:10.1002/hep.24042 · Cited by 79
Rossi, A., Targher, G., Zoppini, G., Cicoira, M., Bonapace, S., Negri, C., Stoico, V., Faggiano, P. M., Vassanelli, C., & Bonora, E. (2012) · Diabetes Care · doi:10.2337/dc12-0134 · Cited by 79
Liver: an alarm for the heart?
Mirbagheri, S. A., Rashidi, A., Abdi, S., Saedi, D., & Abouzari, M. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01531.x · Cited by 78
Postprandial lipemia: An under-recognized atherogenic factor in patients with diabetes mellitus
Pastromas, S. C., Terzi, A. B., Tousoulis, D., & Koulouris, S. N. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.04.172 · Cited by 76
Obstructive sleep apnea syndrome and fatty liver: Association or causal link?
Ahmed, M. H., & Byrne, C.-D. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i34.4243 · Cited by 75
Singh, G. K., Vitola, B. E., Holland, M. R., Sekarski, T. J., Patterson, B. W., Magkos, F., & Klein, S. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2012.11.024 · Cited by 74
Musso, G., Cassader, M., Bo, S., Michieli, F. D., & Gambino, R. (2012) · Diabetes · doi:10.2337/db12-0858 · Cited by 74
Açıkel, M., Sunay, S., Koplay, M., Gündoğdu, F., & Karakelleoğlu, Ş. (2009) · PubMed · Cited by 73
The challenge of developing novel pharmacological therapies for non-alcoholic steatohepatitis
Schuppan, D., Gorrell, M. D., Klein, T., Mark, M., & Afdhal, N. H. (2009) · Liver International · doi:10.1111/j.1478-3231.2010.02264.x · Cited by 73
Cardiovascular risk and atherosclerosis prevention
Frohlich, J. J., & Al-Sarraf, A. J. (2012) · Cardiovascular Pathology · doi:10.1016/j.carpath.2012.03.001 · Cited by 73
Markus, M. R. P., Baumeister, S. E., Stritzke, J., Dörr, M., Wallaschofski, H., Völzke, H., & Lieb, W. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300556 · Cited by 73
The Impact of Bariatric Surgery on Nonalcoholic Steatohepatitis
Rabl, C., & Campos, G. M. (2012) · Seminars in liver disease (Print) · doi:10.1055/s-0032-1306428 · Cited by 72
Lonardo, A., Bellentani, S., Ratziu, V., & Loria, P. (2011) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.11.19 · Cited by 68
GLP ‐1 analogue prevents NAFLD in ApoE KO mice with diet and Acrp30 knockdown by inhibiting c‐ JNK
Zhang, L., Yang, M., Ren, H., Hu, H., Boden, G. H., Li, L., & Yang, G. (2013) · Liver International · doi:10.1111/liv.12120 · Cited by 67
Potential for statins in the chemoprevention and management of hepatocellular carcinoma
Lonardo, A., & Loria, P. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2012.07232.x · Cited by 67
Sert, A., Aypar, E., Pirgon, Ö., Yılmaz, H. S., Odabaş, D., & Tolu, İ. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.03.056 · Cited by 66
Mantovani, A., Zoppini, G., Targher, G., Golia, G., & Bonora, E. (2012) · Journal of Endocrinological Investigation · doi:10.1007/bf03345421 · Cited by 63
γ-Glutamyltransferase, Hepatic Enzymes, and Risk of Incident Heart Failure in Older Men
Wannamethee, S. G., Whincup, P. H., Shaper, A. G., LENNON, L. T., & Sattar, N. A. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.240457 · Cited by 63
Assy, N. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i37.5834 · Cited by 60
Vitamin D, Calcium, and Atherosclerotic Risk: Evidence from Serum Levels and Supplementation Studies
Lutsey, P. L., & Michos, E. D. (2012) · Current Atherosclerosis Reports · doi:10.1007/s11883-012-0293-5 · Cited by 60
Desmosterol in Human Nonalcoholic Steatohepatitis
Simonen, M., Männistö, V., Leppänen, J., Kamińska, D., Kärjä, V. J., Venesmaa, S., Käkelä, P., Kuusisto, J., Gylling, H., Laakso, M., et al. (2013) · Hepatology · doi:10.1002/hep.26342 · Cited by 59
Fatty liver, carotid disease and gallstones: A study of age-related associations
Lonardo, A., Lombardini, S., Scaglioni, F., Ballestri, S., Verrone, A.-M., Bertolotti, M., Carulli, L., Ganazzi, D., Carulli, N., & Loria, P. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i36.5826 · Cited by 58
Self-citationByrne, C. D., & Targher, G. (2013) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0033-1334866 · Cited by 58
Ağaç, M. T., Korkmaz, L., Çavuşoğlu, İ. G., Karadeniz, A. G., Ağaç, S., Bektas, H., Erkan, H., Varol, M. O., Vatan, M. B., Acar, Z., et al. (2013) · Angiology · doi:10.1177/0003319713479155 · Cited by 58
Alp, H., Karaarslan, S., Eklioğlu, B. S., Atabek, M. E., Altın, H., & Baysal, T. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.07.846 · Cited by 57
Nonalcoholic fatty liver in nondiabetic patients with acute coronary syndromes
Boddi, M., Tarquini, R., Chiostri, M., Marra, F., Valente, S., Giglioli, C., Gensini, G. F., & Abbate, R. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12065 · Cited by 55
Lincoff, A. M., Wolski, K., Nicholls, S. J., & Nissen, S. E. (2007) · JAMA · doi:10.1001/jama.298.10.1180 · Cited by 52
Lonardo, A., Bellini, M., Tondelli, E., Frazzoni, M., Grisendi, A., Pulvirenti, M., & Casa, G. D. (1995) · PubMed · Cited by 47
Thrombotic risk factors and liver histologic lesions in non-alcoholic fatty liver disease
Papatheodoridis, G., Chrysanthos, N. V., Cholongitas, Ε., Pavlou, E. G., Apergis, G. A., TINIAKOS, D. G., Andrioti, E., Theodossiades, G., & Archimandritis, A. J. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.06.023 · Cited by 46
Kardassis, D., Bech‐Hanssen, O., Schönander, M., Sjöström, L., & Karason, K. (2011) · Obesity · doi:10.1038/oby.2011.101 · Cited by 46
Lerchbaum, E., Pilz, S., Grammer, T. B., Boehm, B. O., Stojaković, T., Obermayer-Pietsch, B. M., & März, W. (2013) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2013.02.004 · Cited by 43
Alper, A. T., Hasdemir, H., Şahin, S., Öntürk, E., Akyol, A., Nurkalem, Z., Çakmak, N., Erdinler, I. C., & Gürkan, K. (2008) · PubMed · Cited by 42
Maurantonio, M., Ballestri, S., Odoardi, M. R., Lonardo, A., & Loria, P. (2011) · Archives of Medical Research · doi:10.1016/j.arcmed.2011.08.004 · Cited by 42
Self-citationVepsäläinen, T., Soinio, M., Marniemi, J., Lehto, S., Juutilainen, A., Laakso, M., & Rönnemaa, T. (2011) · Diabetes Care · doi:10.2337/dc11-0469 · Cited by 42
Wajcberg, E., & Tavaria, A. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560802611832 · Cited by 41
Nyrnes, A., Njølstad, I., Mathiesen, E. B., Wilsgaard, T., Hansen, J., Skjelbakken, T., Jørgensen, L., & Løchen, M. (2012) · Gender Medicine · doi:10.1016/j.genm.2012.09.001 · Cited by 39
Relationship of hepatic steatosis and alanine aminotransferase with coronary calcification
Jung, D., Lee, Y., Ahn, H. Y., Shim, J., & Lee, H.-R. (2010) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2010.349 · Cited by 36
Jiang, Z., Xu, C., Chang, X.-X., Li, W., Sun, L., Yang, X., & Yu, L.-F. (2013) · BMC Gastroenterology · doi:10.1186/1471-230x-13-110 · Cited by 35
Cardiovascular Disease and Nonalcoholic Fatty Liver Disease
Domanski, J. P., Park, S. J., & Harrison, S. A. (2012) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31822fb3f7 · Cited by 33
Nonalcoholic Fatty Liver Disease and Reduced Serum Vitamin D 3 Levels
Targher, G., Scorletti, E., Mantovani, A., & Byrne, C. D. (2013) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2013.0044 · Cited by 32
Jakovljević, D. G., Hallsworth, K., Zalewski, P., Thoma, C., Klawe, J. J., Day, C. P., Newton, J. L., & Trenell, M. I. (2013) · Clinical Science · doi:10.1042/cs20120684 · Cited by 30
Arslan, U., Kocaoğlu, İ., Balcı, M. M., Duyuler, S., & Korkmaz, A. (2012) · Journal of Cardiology · doi:10.1016/j.jjcc.2012.05.003 · Cited by 24
Sonographic Evaluation for Predicting the Presence and Severity of Coronary Artery Disease
İnci, M. F., Özkan, F., Ark, B., Vurdem, Ü. E., Ege, M. R., Sıncer, İ., & Zorlu, A. (2013) · Ultrasound Quarterly · doi:10.1097/ruq.0b013e318291580e · Cited by 16
Classical and Innovative Insulin Sensitizing Drugs for the Prevention and Treatment of NAFLD
Carulli, L., Maurantonio, M., Hebbard, L., Baldelli, E., Loria, P., & George, J. (2012) · Current Pharmaceutical Design · doi:10.2174/1381612811319290009 · Cited by 8
Cited by
Byrne, C. D., & Targher, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.012 · Cited by 3,042
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
Targher, G., Byrne, C. D., Lonardo, A., Zoppini, G., & Barbui, C. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.013 · Cited by 1,424
Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
Lonardo, A., Nascimbeni, F., Mantovani, A., & Targher, G. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.09.021 · Cited by 736
Non-alcoholic fatty liver disease and dyslipidemia: An update
Katsiki, N., Mikhailidis, D. P., & Mantzoros, C. S. (2016) · Metabolism · doi:10.1016/j.metabol.2016.05.003 · Cited by 564
Francque, S. M., van der Graaff, D., & Kwanten, W. J. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.04.005 · Cited by 556
Metadata
- Authors
- Ballestri, S.
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2014
- Volume
- 20
- Issue
- 7
- Pages
- 1724
- ISSN
- 1007-9327 (ISSN-L)
- OpenAlex
- W2029498977
- Cited by
- 262
- References
- 176
- FWCI
- 19.37
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.